- Home
- BCG vs NMTC Comparison
BCG vs NMTC Comparison
Compare BCG & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCG | NMTC |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 31.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BCG | NMTC |
|---|---|---|
| Price | $2.69 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.23 |
| AVG Volume (30 Days) | 44.3K | ★ 319.2K |
| Earning Date | 11-13-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $178,203,000.00 | $12,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.19 |
| P/E Ratio | $73.62 | ★ N/A |
| Revenue Growth | 10.19 | ★ 250.35 |
| 52 Week Low | $1.36 | $0.40 |
| 52 Week High | $5.81 | $1.39 |
Technical Indicators
Market Signals| Indicator | BCG | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 61.35 | 63.63 |
| Support Level | $2.17 | $0.68 |
| Resistance Level | $3.25 | $0.82 |
| Average True Range (ATR) | 0.29 | 0.08 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 68.46 | 77.25 |
Price Performance
Historical ComparisonAbout BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.